[PDF][PDF] Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically

…, NJ Wilson, PK Ziegler, PM Nguyen, A Preaudet… - Cancer cell, 2013 - cell.com
Among the cytokines linked to inflammation-associated cancer, interleukin (IL)-6 drives
many of the cancer "hallmarks" through downstream activation of the gp130/STAT3 signaling …

[HTML][HTML] mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice

…, TL Putoczki, M Buchert, A Preaudet… - The Journal of …, 2013 - Am Soc Clin Investig
Gastrointestinal cancers are frequently associated with chronic inflammation and excessive
secretion of IL-6 family cytokines, which promote tumorigenesis through persistent activation …

[HTML][HTML] NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease

…, LF Wockner, A Preaudet… - Nature …, 2018 - nature.com
Anti-microbial signaling pathways are normally triggered by innate immune receptors when
detecting pathogenic microbes to provide protective immunity. Here we show that the …

[PDF][PDF] Loss of NF-κB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-dependent manner

…, TL Putoczki, LA Mielke, JT Low, A Lin, A Preaudet… - Immunity, 2018 - cell.com
Polymorphisms in NFKB1 that diminish its expression have been linked to human inflammatory
diseases and increased risk for epithelial cancers. The underlying mechanisms are …

Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism

…, SM Ruwanpura, J Balic, T Livis, C Girard, A Preaudet… - Cancer research, 2018 - AACR
Inflammasomes are key regulators of innate immunity in chronic inflammatory disorders and
autoimmune diseases, but their role in inflammation-associated tumorigenesis remains ill-…

ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling

…, F Zunke, C Becker-Pauly, A Preaudet… - Journal of Experimental …, 2018 - rupress.org
Colorectal cancer is treated with antibodies blocking epidermal growth factor receptor (EGF-R),
but therapeutic success is limited. EGF-R is stimulated by soluble ligands, which are …

[PDF][PDF] Inhibition of hematopoietic cell kinase activity suppresses myeloid cell-mediated colon cancer progression

AR Poh, CG Love, F Masson, A Preaudet, C Tsui… - Cancer Cell, 2017 - cell.com
Aberrant activation of the SRC family kinase hematopoietic cell kinase (HCK) triggers
hematological malignancies as a tumor cell-intrinsic oncogene. Here we find that high HCK levels …

[HTML][HTML] Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival

Q Huang, N Jacquelot, A Preaudet, S Hediyeh-Zadeh… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer is the second leading cause of cancer-related death
worldwide. The immune system plays a key role in controlling tumour onset and development. …

MACROD2 Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal Tumors

…, S Li, L Whitehead, TL Putoczki, A Preaudet… - Cancer discovery, 2018 - AACR
ADP-ribosylation is an important posttranslational protein modification that regulates diverse
biological processes, controlled by dedicated transferases and hydrolases. Here, we show …

Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice

S Alvarez-Diaz, A Preaudet, AL Samson… - Cell Death & …, 2021 - nature.com
Chronic inflammation of the large intestine is associated with an increased risk of developing
colorectal cancer (CRC), the second most common cause of cancer-related deaths …